Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
AMRN Amarin
- 0.553
- +0.003+0.60%
Close Jan 8 16:00 ET
- 0.550
- -0.003-0.58%
Post 19:48 ET
227.59MMarket Cap-5.53P/E (TTM)
0.570High0.524Low1.37MVolume0.556Open0.550Pre Close756.74KTurnover0.36%Turnover RatioLossP/E (Static)411.34MShares1.37052wk High0.43P/B212.30MFloat Cap0.43052wk Low--Dividend TTM383.70MShs Float675.000Historical High--Div YieldTTM8.27%Amplitude0.430Historical Low0.552Avg Price1Lot Size
About Amarin Company
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAMRN
Company NameAmarin
Listing DateApr 1, 1993
Issue Price6.00
Founded1989
CEOMr. Aaron D. Berg
MarketNASDAQ
Employees275
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressIconic Offices, The Greenway,Block C Ardilaun Court, 112–114,St. Stephens Green
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-6699-020
Websitehttp://www.amarincorp.com
Company Executives
- Name
- Position
- Salary
- Aaron D. Berg
- Director, President and Chief Executive Officer
- 2.45M
- Jonathan N. Provoost
- Executive Vice President, Chief Legal and Compliance Officer and Secretary
- 659.26K
- Dr. Steven B. Ketchum, PhD
- Executive Vice President, President, Research and Development and Chief Scientific Officer
- 2.35M
- Peter Fishman
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Odysseas D. Kostas, M.D.
- Chairman of the Board
- 650.41K
- Louis Sterling, III
- Independent Director
- 629.35K
- Oliver O'Connor
- Independent Director
- 611.85K
- Patrice Bonfiglio
- Independent Director
- 626.87K
- Diane E. Sullivan
- Independent Director
- 630.83K
- Dr. Paul Cohen, M.D.
- Independent Director
- 622.06K
- Mark DiPaolo, Esq.
- Independent Director
- 621.00K
- Keith L. Horn
- Independent Director
- 632.09K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.